National brain tumour research funding needs to increase to £35 million a year
National spend on brain tumours remains low
New data from the National Cancer Research Institute (NCRI) shows that brain tumour research still represents just 1% of the national spend on cancer.
We welcome the increase in spend on brain tumour research from £14.2 million to £15.5 million, of which Brain Tumour Research contributed £1.3 million.
In the 2019 / 20 pre-covid financial year, brain tumour research represented 2.33% of the £669 million national spend on cancer, but over the 18 years since records began it still represents just 1%.
The spend on breast cancer remained at 7.76% and at £52 million is £35 million more than the amount spent on brain tumour research.
The spend on leukaemia remained at £35 million (5.2%), prostate £25 million (3.80%), yet brain tumours are still the biggest cancer killer of children and adults under the age of 40.
112,260 people signed our petition demanding action.
We call on the Government to:
- Introduce a new levelling up brain tumour research fund of £105 million
- Increase the national investment into brain tumour research to £35 million a year
- Demonstrate joined-up thinking for investment across the brain tumour research pipeline
Research into brain tumours must not be left behind – the nation needs to Level Up and invest at least £35 million a year if we are to find a cure for brain tumours in the next 20 years.
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.